Ikuo Konishi mainly focuses on Cancer research, Pathology, Internal medicine, Ovarian cancer and Endocrinology. Ikuo Konishi interconnects Cell growth, DNA methylation, Ovarian carcinoma, Carcinogenesis and Downregulation and upregulation in the investigation of issues within Cancer research. Pathology is closely attributed to Adenocarcinoma in his study.
His studies deal with areas such as Cyclopamine, Hedgehog signaling pathway, Progesterone receptor and Oncology as well as Internal medicine. His Ovarian cancer study combines topics from a wide range of disciplines, such as Tumor microenvironment, Vascular endothelial growth factor, Antibody, Immunology and Snail. His work deals with themes such as Receptor, Mesenchymal stem cell, Transplantation and Pregnancy, which intersect with Endocrinology.
His primary areas of investigation include Internal medicine, Pathology, Cancer research, Ovarian cancer and Endocrinology. His work in Internal medicine covers topics such as Oncology which are related to areas like Cervical cancer. His Pathology research includes elements of Ovary, Uterus and Adenocarcinoma.
His work in Cancer research addresses subjects such as Ovarian carcinoma, which are connected to disciplines such as Serous fluid. His Ovarian cancer study incorporates themes from Immunology and Cisplatin. His research in Endocrinology intersects with topics in Fetus, Placenta and Progesterone receptor.
Internal medicine, Ovarian cancer, Cancer research, Oncology and Cancer are his primary areas of study. His Internal medicine research incorporates themes from Gastroenterology and Endocrinology. His studies in Ovarian cancer integrate themes in fields like Cell, Chemotherapy, Cisplatin, Immunology and Gene.
The concepts of his Cancer research study are interwoven with issues in Cell culture, CD8, Cell growth and Myeloid-derived Suppressor Cell. His Oncology research includes elements of Clear cell carcinoma, Ovarian carcinoma, Carboplatin, Randomized controlled trial and Serous fluid. His Pathology research is multidisciplinary, relying on both Gene expression and Nuclear medicine.
The scientist’s investigation covers issues in Immunology, Internal medicine, Cancer research, Ovarian cancer and Oncology. His Immunology course of study focuses on Cancer and Gynecologic oncology. His studies deal with areas such as Endocrinology, Heterologous and Sarcoma as well as Internal medicine.
Ikuo Konishi combines subjects such as Immunohistochemistry, Cell growth, Downregulation and upregulation, CD8 and Myeloid-derived Suppressor Cell with his study of Cancer research. His work carried out in the field of Ovarian cancer brings together such families of science as Cell, Cisplatin, Bioinformatics, Regimen and Serous fluid. His biological study deals with issues like Stage, which deal with fields such as Laparotomy, Debulking and Chemotherapy.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Safety and Antitumor Activity of Anti–PD-1 Antibody, Nivolumab, in Patients With Platinum-Resistant Ovarian Cancer
Junzo Hamanishi;Masaki Mandai;Takafumi Ikeda;Manabu Minami.
Journal of Clinical Oncology (2015)
IFN-γ From Lymphocytes Induces PD-L1 Expression and Promotes Progression of Ovarian Cancer
K Abiko;N Matsumura;J Hamanishi;N Horikawa.
British Journal of Cancer (2015)
Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasms: correlation with clinicopathology and patient survival, and analysis of serum VEGF levels.
S Yamamoto;I Konishi;M Mandai;H Kuroda.
British Journal of Cancer (1997)
Endometrial cysts: diagnosis with MR imaging.
K Togashi;K Nishimura;I Kimura;Y Tsuda.
Hypoxia attenuates the expression of E-cadherin via up-regulation of SNAIL in ovarian carcinoma cells.
Tsutomu Imai;Akiko Horiuchi;Cuiju Wang;Kenji Oka.
American Journal of Pathology (2003)
Multicenter Phase II Study of Fertility-Sparing Treatment With Medroxyprogesterone Acetate for Endometrial Carcinoma and Atypical Hyperplasia in Young Women
Kimio Ushijima;Hideaki Yahata;Hiroyuki Yoshikawa;Ikuo Konishi.
Journal of Clinical Oncology (2007)
Chemotherapy Induces Programmed Cell Death-Ligand 1 Overexpression via the Nuclear Factor-κB to Foster an Immunosuppressive Tumor Microenvironment in Ovarian Cancer
Jin Peng;Junzo Hamanishi;Noriomi Matsumura;Kaoru Abiko.
Cancer Research (2015)
Unusual appearances of uterine leiomyomas: MR imaging findings and their histopathologic backgrounds.
Hiroyuki Ueda;Kaori Togashi;Ikuo Konishi;Milliam L. Kataoka.
Enlarged uterus: differentiation between adenomyosis and leiomyoma with MR imaging.
K Togashi;H Ozasa;I Konishi;H Itoh.
Dual Faces of IFNγ in Cancer Progression: A Role of PD-L1 Induction in the Determination of Pro- and Antitumor Immunity
Masaki Mandai;Junzo Hamanishi;Kaoru Abiko;Noriomi Matsumura.
Clinical Cancer Research (2016)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: